Aurinia Pharmaceuticals Inc. (AUPH) — DEFA14A Filings
All DEFA14A filings from Aurinia Pharmaceuticals Inc.. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (3)
-
Aurinia Pharmaceuticals Files Proxy Materials
— Apr 30, 2025 Risk: low
Aurinia Pharmaceuticals Inc. filed a Definitive Additional Materials proxy statement (DEFA14A) on April 30, 2025. This filing is related to the company's proxy -
Aurinia Pharmaceuticals Files Proxy Materials
— Apr 29, 2025 Risk: low
Aurinia Pharmaceuticals Inc. filed a Definitive Additional Materials proxy statement on April 29, 2025. The filing pertains to the company's proxy materials, in -
Aurinia Pharmaceuticals Files Proxy Supplement
— Jun 4, 2024 Risk: low
Aurinia Pharmaceuticals Inc. filed a Definitive Additional Materials (DEFA14A) on June 4, 2024, related to its 2024 Annual General Meeting. This filing suppleme
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX